Large-scale testing (Phase 3)UnknownNCT00168896What this trial is testingSmall Cell Lung Cancer (SCLC) in Extensive Disease StageWho this might be right forSmall Cell Lung Cancer Charite University, Berlin, Germany 286
Testing effectiveness (Phase 2)Looking for participantsNCT06243003What this trial is testingWBRT With Hippocampal-avoidance Technique Followed by SRT for Extensive-stage SCLC With Baseline Brain MetastasesWho this might be right forSCLC,Extensive StageBrain Metastases Fudan University 56
Testing effectiveness (Phase 2)Ended earlyNCT01573338What this trial is testingClinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 When Given Together With Chemotherapy and the Effectiveness of This Combination Treatment in Shrinking a Specific Type of Lung Tumors (Small Cell Lung Cancer)Who this might be right forSmall Cell Lung Carcinoma Bayer 43
Testing effectiveness (Phase 2)Study completedNCT00104793What this trial is testingIrinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung CancerWho this might be right forLung Cancer Japan Multinational Trial Organization 55
Not applicableStudy completedNCT00416689What this trial is testingNausea or Vomiting in Patients Who Are Receiving Chemotherapy for Breast Cancer or Lung CancerWho this might be right forBreast CancerLung CancerNausea and Vomiting Alliance for Clinical Trials in Oncology 99
Testing effectiveness (Phase 2)Ended earlyNCT00084487What this trial is testingRebeccamycin Analog as Second-Line Therapy in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer That Relapsed After Previous First-Line ChemotherapyWho this might be right forExtensive Stage Small Cell Lung CancerLimited Stage Small Cell Lung CancerRecurrent Small Cell Lung Cancer National Cancer Institute (NCI) 21
Early research (Phase 1)Ended earlyNCT03963414What this trial is testingDurvalumab Plus Tremelimumab With Chemotherapy in Untreated ES-SCLCWho this might be right forSmall Cell Lung Carcinoma University of Nebraska 1
Testing effectiveness (Phase 2)UnknownNCT01441349What this trial is testingIrinotecan/Cisplatin With or Without Simvastatin in Chemo-naive Patients With Extensive Disease-small Cell Lung CancerWho this might be right forSmall Cell Lung Carcinoma National Cancer Center, Korea 192
Large-scale testing (Phase 3)Active Not RecruitingNCT04155034What this trial is testingS1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung CancerWho this might be right forExtensive Stage Lung Small Cell CarcinomaLimited Stage Lung Small Cell CarcinomaLung Small Cell Carcinoma SWOG Cancer Research Network 668
Not applicableStudy completedNCT01416688What this trial is testingS1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib HydrochlorideWho this might be right forColorectal CancerDermatologic ComplicationsLung Cancer+1 more SWOG Cancer Research Network 146
Not applicableStudy completedNCT00905086What this trial is testingPsychosocial Adjustment After Radiation Therapy in Patients With CancerWho this might be right forBreast CancerCognitive/Functional EffectsColorectal Cancer+3 more Case Comprehensive Cancer Center 80
Testing effectiveness (Phase 2)UnknownNCT02504346What this trial is testingAZD9291, an Irreversible EGFR-TKI, in Relapsed EGFR-mutated Non-small Cell Lung Cancer Patients Previously Treated With an EGFR-TKI, Coupled to Extensive Translational StudiesWho this might be right forLung CancerTargeted Therapy Oslo University Hospital 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT04728230What this trial is testingOlaparib and Durvalumab With Carboplatin, Etoposide, and/or Radiation Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer, PRIO TrialWho this might be right forExtensive Stage Lung Small Cell CarcinomaStage IV Lung Cancer AJCC v8Stage IVA Lung Cancer AJCC v8+1 more M.D. Anderson Cancer Center 63
Testing effectiveness (Phase 2)UnknownNCT05975944What this trial is testingStudy of Selinexor Combined With Olaparib in Relapsed/Refractory Extensive Stage Small Cell Lung CancerWho this might be right forExtensive-stage Small Cell Lung Cancer Tianjin Medical University Cancer Institute and Hospital 49
Testing effectiveness (Phase 2)UnknownNCT03841136What this trial is testingAnlotinib Combined With Etoposide and Platinum in the Treatment of Lung CancerWho this might be right forExtensive-stage Small Cell Lung Cancer Fudan University 70
Testing effectiveness (Phase 2)Study completedNCT05309629What this trial is testingSafety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy in Extensive-Stage Small Cell Lung CancerWho this might be right forExtensive-stage Small-cell Lung Cancer Qilu Pharmaceutical Co., Ltd. 40
Testing effectiveness (Phase 2)Looking for participantsNCT07508852What this trial is testing68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung CancerWho this might be right forSCLCSCLC, Extensive StageSCLC, Limited Stage+2 more Peking University First Hospital 30
Large-scale testing (Phase 3)Study completedNCT04878016What this trial is testingCarboplatin Plus Etoposide With or Without ZKAB001 (Anti-PD-L1 Antibody) in Patients With ES-SCLCWho this might be right forExtensive-stage Small-cell Lung Cancer Lee's Pharmaceutical Limited 498
Testing effectiveness (Phase 2)Study completedNCT00009971What this trial is testingFenretinide in Treating Patients With Recurrent Small Cell Lung CancerWho this might be right forLung Cancer National Cancer Institute (NCI) 32
Early research (Phase 1)Active Not RecruitingNCT06077500What this trial is testingDAREONᵀᴹ-8: A Study to Test How Well Different Doses of BI 764532 in Addition to Standard of Care Are Tolerated by People With Advanced Small Cell Lung CancerWho this might be right forSmall Cell Lung Carcinoma (SCLC) Boehringer Ingelheim 46